Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Us...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo
Format: Artigo
Idioma:Inglês
Publicat: Wiley 2025-10-01
Col·lecció:ESC Heart Failure
Matèries:
Heart failure, systolic
Hospitalization
Kidney failure, chronic
Mortality
Renin‐angiotensin system
Treatment outcome
Accés en línia:https://doi.org/10.1002/ehf2.15359
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars